Literature DB >> 27357661

Structural model of the dimeric Parkinson's protein LRRK2 reveals a compact architecture involving distant interdomain contacts.

Giambattista Guaitoli1, Francesco Raimondi2, Bernd K Gilsbach3, Yacob Gómez-Llorente4, Egon Deyaert5, Fabiana Renzi4, Xianting Li6, Adam Schaffner7, Pravin Kumar Ankush Jagtap8, Karsten Boldt9, Felix von Zweydorf1, Katja Gotthardt10, Donald D Lorimer11, Zhenyu Yue6, Alex Burgin12, Nebojsa Janjic13, Michael Sattler8, Wim Versées5, Marius Ueffing9, Iban Ubarretxena-Belandia14, Arjan Kortholt15, Christian Johannes Gloeckner16.   

Abstract

Leucine-rich repeat kinase 2 (LRRK2) is a large, multidomain protein containing two catalytic domains: a Ras of complex proteins (Roc) G-domain and a kinase domain. Mutations associated with familial and sporadic Parkinson's disease (PD) have been identified in both catalytic domains, as well as in several of its multiple putative regulatory domains. Several of these mutations have been linked to increased kinase activity. Despite the role of LRRK2 in the pathogenesis of PD, little is known about its overall architecture and how PD-linked mutations alter its function and enzymatic activities. Here, we have modeled the 3D structure of dimeric, full-length LRRK2 by combining domain-based homology models with multiple experimental constraints provided by chemical cross-linking combined with mass spectrometry, negative-stain EM, and small-angle X-ray scattering. Our model reveals dimeric LRRK2 has a compact overall architecture with a tight, multidomain organization. Close contacts between the N-terminal ankyrin and C-terminal WD40 domains, and their proximity-together with the LRR domain-to the kinase domain suggest an intramolecular mechanism for LRRK2 kinase activity regulation. Overall, our studies provide, to our knowledge, the first structural framework for understanding the role of the different domains of full-length LRRK2 in the pathogenesis of PD.

Entities:  

Keywords:  CL-MS; EM; LRRK2; Parkinson’s disease; structural modeling

Mesh:

Substances:

Year:  2016        PMID: 27357661      PMCID: PMC4968714          DOI: 10.1073/pnas.1523708113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  82 in total

1.  EMAN: semiautomated software for high-resolution single-particle reconstructions.

Authors:  S J Ludtke; P R Baldwin; W Chiu
Journal:  J Struct Biol       Date:  1999-12-01       Impact factor: 2.867

2.  Xmipp: An Image Processing Package for Electron Microscopy

Authors: 
Journal:  J Struct Biol       Date:  1996-10       Impact factor: 2.867

3.  Enhanced striatal dopamine transmission and motor performance with LRRK2 overexpression in mice is eliminated by familial Parkinson's disease mutation G2019S.

Authors:  Xianting Li; Jyoti C Patel; Jing Wang; Marat V Avshalumov; Charles Nicholson; Joseph D Buxbaum; Gregory A Elder; Margaret E Rice; Zhenyu Yue
Journal:  J Neurosci       Date:  2010-02-03       Impact factor: 6.167

Review 4.  The Roco protein family: a functional perspective.

Authors:  Ignacio Marín; Wouter N van Egmond; Peter J M van Haastert
Journal:  FASEB J       Date:  2008-06-03       Impact factor: 5.191

Review 5.  The GTPase function of LRRK2.

Authors:  Jean-Marc Taymans
Journal:  Biochem Soc Trans       Date:  2012-10       Impact factor: 5.407

Review 6.  Probing native protein structures by chemical cross-linking, mass spectrometry, and bioinformatics.

Authors:  Alexander Leitner; Thomas Walzthoeni; Abdullah Kahraman; Franz Herzog; Oliver Rinner; Martin Beck; Ruedi Aebersold
Journal:  Mol Cell Proteomics       Date:  2010-03-31       Impact factor: 5.911

7.  LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in mice.

Authors:  Martin C Herzig; Carine Kolly; Elke Persohn; Diethilde Theil; Tatjana Schweizer; Thomas Hafner; Christine Stemmelen; Thomas J Troxler; Peter Schmid; Simone Danner; Christian R Schnell; Matthias Mueller; Bernd Kinzel; Armelle Grevot; Federico Bolognani; Martina Stirn; Rainer R Kuhn; Klemens Kaupmann; P Herman van der Putten; Giorgio Rovelli; Derya R Shimshek
Journal:  Hum Mol Genet       Date:  2011-08-09       Impact factor: 6.150

8.  Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega.

Authors:  Fabian Sievers; Andreas Wilm; David Dineen; Toby J Gibson; Kevin Karplus; Weizhong Li; Rodrigo Lopez; Hamish McWilliam; Michael Remmert; Johannes Söding; Julie D Thompson; Desmond G Higgins
Journal:  Mol Syst Biol       Date:  2011-10-11       Impact factor: 11.429

Review 9.  Structural biology of the LRRK2 GTPase and kinase domains: implications for regulation.

Authors:  Bernd K Gilsbach; Arjan Kortholt
Journal:  Front Mol Neurosci       Date:  2014-05-05       Impact factor: 5.639

10.  Analysis Tool Web Services from the EMBL-EBI.

Authors:  Hamish McWilliam; Weizhong Li; Mahmut Uludag; Silvano Squizzato; Young Mi Park; Nicola Buso; Andrew Peter Cowley; Rodrigo Lopez
Journal:  Nucleic Acids Res       Date:  2013-05-13       Impact factor: 16.971

View more
  52 in total

1.  Structure, function, and leucine-rich repeat kinase 2: On the importance of reproducibility in understanding Parkinson's disease.

Authors:  Mark R Cookson
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-15       Impact factor: 11.205

Review 2.  Potential for therapeutic targeting of AKAP signaling complexes in nervous system disorders.

Authors:  Angela R Wild; Mark L Dell'Acqua
Journal:  Pharmacol Ther       Date:  2017-12-17       Impact factor: 12.310

3.  The LRR-Roc-COR module of the Chlorobium tepidum Roco protein: crystallization and X-ray crystallographic analysis.

Authors:  Egon Deyaert; Arjan Kortholt; Wim Versées
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2017-08-21       Impact factor: 1.056

4.  The dual enzyme LRRK2 hydrolyzes GTP in both its GTPase and kinase domains in vitro.

Authors:  Zhiyong Liu; Andrew B West
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2016-12-08       Impact factor: 3.036

Review 5.  Mechanisms of LRRK2-dependent neurodegeneration: role of enzymatic activity and protein aggregation.

Authors:  Md Shariful Islam; Darren J Moore
Journal:  Biochem Soc Trans       Date:  2017-02-08       Impact factor: 5.407

6.  Parkinson's Disease-Associated LRRK2 Hyperactive Kinase Mutant Disrupts Synaptic Vesicle Trafficking in Ventral Midbrain Neurons.

Authors:  Ping-Yue Pan; Xianting Li; Jing Wang; James Powell; Qian Wang; Yuanxi Zhang; Zhaoyu Chen; Bridget Wicinski; Patrick Hof; Timothy A Ryan; Zhenyu Yue
Journal:  J Neurosci       Date:  2017-10-20       Impact factor: 6.167

Review 7.  Achieving neuroprotection with LRRK2 kinase inhibitors in Parkinson disease.

Authors:  Andrew B West
Journal:  Exp Neurol       Date:  2017-07-29       Impact factor: 5.330

Review 8.  Organoid and pluripotent stem cells in Parkinson's disease modeling: an expert view on their value to drug discovery.

Authors:  Nick Marotta; Soojin Kim; Dimitri Krainc
Journal:  Expert Opin Drug Discov       Date:  2020-01-03       Impact factor: 6.098

9.  The Parkinson's disease-associated mutation N1437H impairs conformational dynamics in the G domain of LRRK2.

Authors:  Xiaorong Huang; Chunxiang Wu; Yangshin Park; Xuwei Long; Quyen Q Hoang; Jingling Liao
Journal:  FASEB J       Date:  2018-12-28       Impact factor: 5.191

10.  The In Situ Structure of Parkinson's Disease-Linked LRRK2.

Authors:  Reika Watanabe; Robert Buschauer; Jan Böhning; Martina Audagnotto; Keren Lasker; Tsan-Wen Lu; Daniela Boassa; Susan Taylor; Elizabeth Villa
Journal:  Cell       Date:  2020-08-11       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.